Concepedia

Author

E. McKinnon

Murdoch UniversityORCID

Also Known As

Chua, A., E McKinnon, E. J. Gregory McKinnon, E. J. McKinnon, E. McKinnon, E.J. McKinnon, Elizabeth J McKinnon, Elizabeth J Mckinnon, Elizabeth J. McKinnon, Elizabeth J. Mckinnon

173

Publications

3.8K

Citations

27

H-Index

92

Concepts

All Affiliations

Murdoch UniversityRoyal Perth HospitalThe University of Western AustraliaVanderbilt UniversityThe Kids Research Institute Australia
EM

About

E. McKinnon is an author at Murdoch University specializing in medicine, immunology, and hiv.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

14

771

2

Public Health

5

5

418

3

Education

1

1

11

4

Engineering

1

1

24

5

Nursing

1

1

12

E. McKinnon

×

45

Publications

3.6K

Citations

27

H-Index

YearCitations

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

S. Mallal, Mina John, Corey Moore,

AIDS

2000

523

Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy

Martyn A. French, Nat Lenzo, Mina John,

HIV Medicine

2000

411

Prospective Genetic Screening Decreases the Incidence of Abacavir Hypersensitivity Reactions in the Western Australian HIV Cohort Study

Andri Rauch, David Nolan, A. Martin,

Clinical Infectious Diseases

2006

301

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy

David Nolan, E. Hammond, A. Martin,

AIDS

2003

266

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

Mina John, Corey Moore, Ian James,

AIDS

2001

264

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir

David Nolan, Richard Upton, E. McKinnon,

AIDS

2001

165

Contribution of Nucleoside-Analogue Reverse Transcriptase Inhibitor Therapy to Lipoatrophy from the Population to the Cellular Level

David Nolan, E. Hammond, Ian James,

Antiviral Therapy

2003

129

Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression

Silvana Gaudieri, David DeSantis, E. McKinnon,

Genes and Immunity

2005

127

Randomized, Controlled, 48-Week Study of Switching Stavudine and/or Protease Inhibitors to Combivir/Abacavir to Prevent or Reverse Lipoatrophy in HIV-Infected Patients

Mina John, E. McKinnon, Ian James,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2003

112

HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection

S. Herrmann, E. McKinnon, N. Hyland,

Health and Quality of Life Outcomes

2013

90

Page 1